ArticlePostgraduate medicine2011

Review of the safety and efficacy of linagliptin as add-on therapy to metformin in patients with type 2 diabetes: a randomized, double-blind, placebo-controlled study.

Marc Rendell et al.PubMed ↗Publisher ↗

No numbers read from the abstract.